Newly released Spatial Mass Spectrometry Market Share analysis report by Future Market Insights shows that global sales of Spatial Mass Spectrometry Market in 2021 was held at US$ 224.1 Mn. With 15.3%, the projected market growth during 2022 – 2032 is expected to be significantly higher than the historical growth.
Spatial Transcriptomics is expected to be the highest revenue generating technology, projected to grow at a CAGR of over 16.6% during 2022 – 2032.
Global Spatial Mass Spectrometry Market CAGR (2022-2032)
15.3%
Global Spatial Mass Spectrometry Market Size (2022)
US$ 254.8 Mn
Global Spatial Mass Spectrometry Market Size (2032)
US$ 1 Bn
U.S. Spatial Mass Spectrometry Market CAGR (2022-2032)
14.8%
Key Companies Covered
- 10x Genomics
- Dovetail Genomics
- S2 Genomics Inc
- NanoString Technologies Inc
- Seven Bridges Genomics
- PerkinElmer, Inc.
- Bio-Techne
- Danaher Corporation
- IonPath, Inc.
Request Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15091
Revenue Of Spatial Mass Spectrometry Market From 2017 To 2021 Compared To Demand Outlook For 2022 To 2032
As per the Spatial Mass Spectrometry Market research by Future Market Insights – a market research and competitive intelligence provider, historically, from 2017 to 2021, market value of the Spatial Mass Spectrometry Market increased at around 12.7% CAGR.
The factors pushing the Spatial Mass Spectrometry Market growth include the growing cancer prevalence and incidence rates. Geographical omics combines molecular analysis with geographical data on the location of a cell within a tissue.
Omics is a broad term that includes epigenomics, genomics, transcriptomics, lipidomics, proteomics, and metabolomics, among other studies. One of the key incentives for Spatial Mass Spectrometry is its high potential as diagnostic tools, notably in oncology.
The market’s modest acceleration is attributable to technological advancements in Spatial Mass Spectrometry combined with aggressive spatial penetration expansion. Geographical analysis provides for improved molecular research regarding spatial information.
New Spatial Mass Spectrometry solutions and products are continually being developed by startups, established players, and expanding enterprises in the market. They’re also participating in mergers and acquisitions, which is hastening the implementation of Spatial Mass Spectrometry around the world.
- Spatial Mass Spectrometry Market was valued at US$ 224.1 Mn in 2021. According to Future Market Insights, Spatial Mass Spectrometry Market revenue would increase 4X between 2022 and 2032, reaching roughly US$ 1.0 Bn in 2032.
- In terms of Technology, the Spatial Transcriptomics accounts for the highest projected CAGR of over 16.6%.
- In terms of Sample Type of Spatial Mass Spectrometry, FFPE accounts for the highest CAGR of 13.3% during the historic period (2017-21).
- US is the dominant market in global Spatial Mass Spectrometry Market with an absolute dollar growth opportunity of over US$ 283.1 Mn.
For More Info on the report make an Enquiry @ https://www.futuremarketinsights.com/ask-question/rep-gb-15091
What Factors Are Propelling The Demand For Spatial Mass Spectrometry?
Companies are employing Spatial Mass Spectrometry to better comprehend molecules during clinical trial investigations. The usage of Spatial Mass Spectrometry in pharmaceutical research and discovery phases promotes substantial growth in the Spatial Mass Spectrometry market.
The rising adoption of spatial genomics and transcriptomics approaches for drug discovery and development, as well as increased R&D investments and public-private funding, are some of the primary drivers of the spatial genomics and transcriptomics market. In addition, the advent of technologically improved devices for spatial genomics analysis is fueling market expansion.
The market for spatial genomics and transcriptomics will grow fast as the potential of spatial genomic analysis with the growth in cancer diagnosis tools, and the arrival of the fourth generation of sequencing. Genome positioning is an intriguing novel biomarker that is required in a range of cancer types.
For a range of medical conditions, spatial patterns in the genome have been uncovered, leading to the use of spatial information as a diagnostic biomarker for a variety of diseases. Biomarkers are in high demand because they make it easier to distinguish between benign and malignant tumours. As a result, there is a growing demand for spatial genomics analysis as a cancer detection tool.
A variety of spatial transcriptomics techniques have been developed and successfully implemented to fulfil the growing demand for a deeper understanding of tissue profiling.
Which Industries Are Pulling The Growth Trigger In Spatial Mass Spectrometry Market?
The use of Spatial Omics in drug discovery and development is becoming more common. During clinical trial investigations, companies are using Spatial Mass Spectrometry to better understand molecules. The use of Spatial Mass Spectrometry in medication development and discovery phases supports huge growth in the Spatial Mass Spectrometry market today and in the near future.
The market for Spatial Mass Spectrometry will expand owing to the upcoming Spatial Mass Spectrometry technologies and improvements. For example, Spatial Transcriptomics, for example, is an in situ capture technology that allows for the quantification and visualization of transcriptomes in particular tissue slices.
The use of Spatial Mass Spectrometry techniques in cancer diagnostics is expected to yield significant results in the near future.
Region-Wise Analysis
Which Region is projected to Offer the Largest Opportunity for Spatial Mass Spectrometry Market?
North America leads the Spatial Mass Spectrometry market, owing to the development of technology to discover illness biomarkers. The market is growing due to rising demand for cancer treatment and the occurrence of cancer in North America, where around 1.2 Mn women get biopsies each year.
And about 20% of them have been told they have breast cancer. Furthermore, the market’s expansion would be aided by the availability of qualified experts and healthcare facilities equipped with cutting-edge diagnostic procedures and medicines throughout the projection period.
In the Spatial Mass Spectrometry market, Asia Pacific held a sizable proportion of the global market. Factors contributing to the region’s growth include an increase in the number of enterprises entering the market, as well as biological activities and research studies, all of which are expected to promote the use of Spatial Mass Spectrometry tools throughout the forecast period.
Country-Wise Analysis
Which Country Lies at the CenterStage for Spatial Mass Spectrometry Market Revenue?
The United States is expected to have the highest market share of US$ 378.4 Mn by the end of 2032. In 2021, the United States had the highest revenue share of over 35%. The market is expanding as the prevalence of chronic diseases including cancer and heart disease rises. Cancer is one of the leading causes of death in the United States. In 2018, around 1,735,350 new cancer diagnoses and 609,640 cancer-related deaths were recorded.
Category-Wise Insights
Which Spatial Mass Spectrometry Segment is projected to Witness Fastest Growth among Spatial Mass Spectrometry Type?
The Spatial Transcriptomics segment is forecasted to grow at the highest CAGR of over 16.6% during 2022-2032. This segment’s growth is fuelled by the introduction of novel tools and instruments. Through this procedure, the technology may aid in the discovery of the subcellular localization of mRNA molecules.
Furthermore, the technology makes the process of studying genomic analysis much easier. This could potentially meet the needs of biological specimens of nucleic acid or single cells. Market growth is expected to be aided by these factors.
These techniques generally promote fields in molecular genetics and biochemistry associated with structure-oriented fields such as embryology and histology. This allows the genomics segment to grow at a faster rate than the rest of the market over the forecasted timeframe.
Which Sample Type of Spatial Mass Spectrometry is expected to Score Highest Growth in the Coming Years?
The FFPE segment is forecasted to grow at the highest CAGR of over 15.8% during 2022-2032. The FFPE sector has the largest market share of around 55% due to breakthroughs in the examination, experimental research, and diagnostic progress. Furthermore, the fresh frozen segment is predicted to grow at the fastest rate due to increased demand.
Competitive Analysis
Among the leading Spatial Mass Spectrometry companies are 10x Genomics, Dovetail Genomics, S2 Genomics Inc, NanoString Technologies Inc, and Seven Bridges Genomics. To gain a competitive advantage in the industry, these market players are investing in partnerships, mergers and acquisitions, and expansion.
Request Discount @ https://www.futuremarketinsights.com/request-discount/rep-gb-15091
Some of the recent developments of key Spatial Mass Spectrometry providers are as follows:
- In June 2021, NanoString Technologies Inc, a prominent provider of life science tools for discovery and translational research, for example, announced new solutions to analyse the immune response in COVID-19 disease research.
- In December 2021, EEL Transcriptomics AB, announced that it has acquired the assay assets and IP of Rebus Biosystems Inc., a life science technology startup based in the United States.
- In November 2021, ICON plc stated that its Accellacare Site Network has expanded its scope and capabilities with new partnerships six research sites in four countries.
- In February 2021, Parexel and Neo Genomics formed a precision medicine strategic alliance, with the purpose to improve study designs and accelerate patient matching in oncology clinical trials.
- In March 2019, Mission Bio and Labcorp partnered to employ single-cell genomics to speed up the creation of tailored medications.
Similarly, recent developments related to companies Spatial Mass Spectrometry services have been tracked by the team at Future Market Insights, which are available in the full report.
Spatial Mass Spectrometry Market Report Scope
Forecast Period
2022-2032
Historical Data Available for
2017-2021
Market Analysis
US$ Mn for Value
Key Regions Covered
North America, Europe, Asia Pacific, Middle East & Africa, Latin America
Key Countries Covered
United States, U.K., China, South Korea, Japan
Key Market Segments Covered
Technology, Product Type, Workflow, Sample Type
Key Companies Profiled
- 10x Genomics
- Dovetail Genomics
- S2 Genomics Inc
- NanoString Technologies Inc
- Seven Bridges Genomics
- PerkinElmer, Inc.
- Bio-Techne
- Danaher Corporation
- IonPath, Inc.
- Millennium Science Pty Ltd.
- Akoya Biosciences, Ltd.
- Fluidigm Corporation
- Diagenode Diagnostics
- Biognosys AG
- Rebus Biosystems
- Ultivue, Inc.
- Vizgen Corp.
- BioSpyder Technologies
- Bruker
- Brooks Automation, Inc.
Market Segments Covered In Spatial Mass Spectrometry Market Analysis
By Technology:
- Spatial Transcriptomics
- Spatial Genomics
- Spatial Proteomics
By Product Type:
- Instruments
- Consumables
- Software
By Workflow:
- Sample Preparation
- Instrumental Analysis
- Data Analysis
By Sample Type:
- FFPE
- Fresh Frozen
By Region:
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
About FMI:
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs